Elsevier

Seminars in Immunology

Volume 38, August 2018, Pages 40-48
Seminars in Immunology

High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells

https://doi.org/10.1016/j.smim.2018.02.011Get rights and content

Highlights

  • TLR4 and RAGE are dominant HMGB1-receptors.

  • HMGB1 forms complexes with other inflammatory molecules which are endocytosed via RAGE.

  • Endocytosed HMGB1 destabilizes lysosomal membranes and the leaking lysosomes allow molecules access to cytosolic sensors.

  • LPS and nucleic acids need HMGB1 to express full toxicity.

  • HMGB1 blockade is of great clinical interest for multiple inflammatory conditions.

Abstract

Alarmins are preformed, endogenous molecules that can be promptly released to signal cell or tissue stress or damage. The ubiquitous nuclear molecule high-mobility group box 1 protein (HMGB1) is a prototypical alarmin activating innate immunity. HMGB1 serves a dual alarmin function. The protein can be emitted to alert adjacent cells about endangered homeostasis of the HMGB1-releasing cell. In addition to this expected path of an alarmin, extracellular HMGB1 can be internalized via RAGE-receptor mediated endocytosis to the endolysosomal compartment while attached to other extracellular proinflammatory molecules. The endocytosed HMGB1 may subsequently destabilize lysosomal membranes. The HMGB1-bound partner molecules depend on the HMGB1-mediated transport and the induced lysosomal leakage to obtain access to endosomal and cytosolic reciprocal sensors to communicate extracellular threat and to initiate the proper activation pathways.

Introduction

Cells in all living organisms are constantly challenged by sterile or infectious stimuli that may cause cellular injury or death. The universal alarm system sensing danger-induced cellular stress utilizes preformed endogenous molecules termed alarmins or damage-associated molecular pattern molecules (DAMPs) for this communication [[1], [2], [3]]. These molecules display other intracellular tasks during homeostatic conditions, but when released extracellularly in response to danger signals they exert immunologic activity that promotes inflammation. The purpose of the discharge of alarmins is to arm cells by adjusting for challenged cellular homeostasis and to initiate repair mechanisms. However, alarmin release may also paradoxically cause tissue injury and organ dysfunction central in the pathogenesis of many acute and chronic diseases [[4], [5], [6]]. Targeting alarmins may conceivably offer a useful novel approach to therapy.

We here focus on the biology of high-mobility group box 1 protein (HMGB1) acting as a typical alarmin [[6], [7], [8]]. After translocation to the outside, HMGB1 operates as a warning signal that induces inflammation via two fundamentally separate means. Extracellular HMGB1 may, like many other alarmins and pathogen-derived mediators, bind directly to cell surface receptors on somatic and immune cells propagating intracellular signaling cascades that mediate inflammation [8,9]. Alternatively, HMGB1 may bind to a number of different soluble extracellular immune-activating molecules that will be endocytosed into the endolysosomal system as HMGB1-bound complexes [10,11]. Inside lysosomes HMGB1 has the capacity to disrupt the lysosome, which enables HMGB1-partner molecules to enter the cytosol [11,12]. The HMGB1-mediated cellular uptake thus enables molecular access to endosomal and cytoplasmic immune receptors reciprocal to HMGB1-partner molecules or to HMGB1 itself. The internalized proinflammatory molecules would not reach and encounter their intracellular sensors without the delivery by HMGB1 via mechanisms to be further outlined.

Section snippets

HMGB1 biology

HMGB1 is an evolutionarily highly preserved nuclear, non-histone DNA-binding protein named for its high electrophoretic mobility on polyacrylamide gels [8]. There are four different HMGBs in mammals, HMGB1-4, but HMGB1 is by far the most abundantly and most ubiquitously expressed [13]. It is an extremely mobile protein inside the cell nucleus, where it influences chromatin structure and enhances the accessibility of binding sites to regulatory elements like transcription factors and

Mechanisms for HMGB1 release

HMGB1 can be discharged to the cellular outside via active and passive routes occurring in both somatic and immune cells. Receptor-mediated HMGB1 release appearing in stimulated cells initially requires hyperacetylation of multiple lysines present in the two HMGB1 nuclear localization sites (NLS) forcing the nuclear HMGB1 to accumulate in the cytoplasm. HMGB1 constantly shuttles between the cytoplasm and the nucleus in a resting cell, but acetylation of lysines in the NLS prevents the nuclear

HMGB1 receptor systems

The list of published HMGB1-receptors described to elicit signal transduction due to extracellular HMGB1 ligation is remarkably long, most likely too long. At least 14 different receptor systems have been reported to be engaged by extracellular HMGB1 (reviewed in [8,9]). All of them were originally discovered as receptors for ligands unrelated to HMGB1. However, only two receptor systems, TLR4 and RAGE, have so far been extensively studied in carefully defined molecular systems and confirmed in

Sepsis

The proinflammatory activity of HMGB1 was first discovered in studies designed to identify novel mediators of sepsis [34]. Administration of lethal doses of endotoxin to mammals activates a biphasic cytokine response that can be divided into early and late kinetic profiles. The classical proinflammatory cytokine response develops early, with peak levels of TNF or IL-1 occurring within a few hours. HMGB1 release takes place significantly later, reaching a plateau 16 to 32 h after the onset of

Conclusions

The ubiquitous nuclear protein HMGB1 can be translocated to the outside of cells and propagate inflammation as an alarmin. The best characterized cell surface receptors for HMGB1-mediated immune functions are TLR4 and RAGE. Apart from operating on its own, HMGB1 also acts in strong synergy with several other potent inflammatory molecules including LPS, DNA, RNA, and IL-1. HMGB1 forms complexes with these mediators and transports them via RAGE-mediated endocytosis to the endolysosomal system.

References (113)

  • P.M. LeBlanc et al.

    An immunogenic peptide in the A-box of HMGB1 protein reverses apoptosis-induced tolerance through RAGE receptor

    J. Biol. Chem.

    (2014)
  • D.J. Antoine et al.

    Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity

    J. Hepatol.

    (2012)
  • M. Van de Wouwer et al.

    The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis

    J. Thromb. Haemost.: JTH

    (2006)
  • C.A. Janeway

    Approaching the asymptote? Evolution and revolution in immunology

    Cold Spring Harb. Symp. Quant. Biol.

    (1989)
  • P. Matzinger

    Tolerance, danger, and the extended family

    Annu. Rev. Immunol.

    (1994)
  • K. Asehnoune et al.

    Understanding why clinicians should care about danger-associated molecular patterns

    Intensive Care Med.

    (2016)
  • D. Bertheloot et al.

    IL-33 and S100 proteins: dual-function alarmins

    Cell. Mol. Immunol.

    (2017)
  • H.E. Harris et al.

    HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease, nature reviews

    Rheumatology

    (2012)
  • U. Andersson et al.

    HMGB1 is a therapeutic target for sterile inflammation and infection

    Annu. Rev. Immunol.

    (2011)
  • J. Tian et al.

    Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

    Nat. Immunol.

    (2007)
  • J. Xu et al.

    Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis

    Cell Death Differ.

    (2014)
  • J. Yang et al.

    Hemorrhagic shock primes for lung vascular endothelial cell pyroptosis: role in pulmonary inflammation following LPS

    Cell. Death Dis.

    (2016)
  • H.W. Choi et al.

    Activation of plant innate immunity by extracellular high mobility group box 3 and its inhibition by salicylic acid

    PLoS Pathog.

    (2016)
  • A.R. Mistry et al.

    Recombinant HMG1 protein produced in Pichia pastoris: a nonviral gene delivery agent

    Biotechniques

    (1997)
  • Y. Tang et al.

    Regulation of posttranslational modifications of HMGB1 during immune responses

    Antioxid. Redox Signaling

    (2016)
  • U. Andersson et al.

    The functions of HMGB1 depend on molecular localization and post-translational modifications

    J. Intern. Med.

    (2014)
  • M. Lamkanfi et al.

    Inflammasome-dependent release of the alarmin HMGB1 in endotoxemia

    J. Immunol.

    (2010)
  • B. Lu et al.

    Novel role of PKR in inflammasome activation and HMGB1 release

    Nature

    (2012)
  • R. Kang et al.

    HMGB1: a novel Beclin 1-binding protein active in autophagy

    Autophagy

    (2010)
  • X. Zhu et al.

    Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation

    J. Clin. Invest.

    (2015)
  • D.J. Antoine et al.

    A systematic nomenclature for the redox states of high mobility group box (HMGB) proteins

    Mol. Med.

    (2014)
  • M. Schiraldi et al.

    HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4

    J. Exp. Med.

    (2012)
  • H. Yang et al.

    MD-2 is required for disulfide HMGB1-dependent TLR4 signaling

    J. Exp. Med.

    (2015)
  • H. Yang et al.

    The many faces of HMGB1: molecular structure-functional activity in inflammation apoptosis, and chemotaxis

    J. Leukoc. Biol.

    (2013)
  • T. Bonaldi et al.

    Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion

    EMBO J.

    (2003)
  • J. Evankovich et al.

    High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity

    J. Biol. Chem.

    (2010)
  • J.Y. Zou et al.

    Release of neuronal HMGB1 by ethanol through decreased HDAC activity activates brain neuroimmune signaling

    PLoS One

    (2014)
  • J.S. Hwang et al.

    Deacetylation-mediated interaction of SIRT1-HMGB1 improves survival in a mouse model of endotoxemia

    Sci. Rep.

    (2015)
  • S. Gardella et al.

    The nuclear protein HMGB1 is secreted by monocytes via a non-classical vesicle-mediated secretory pathway

    EMBO Rep.

    (2002)
  • D.S. Pisetsky

    The expression of HMGB1 on microparticles released during cell activation and cell death in vitro and in vivo

    Mol. Med.

    (2014)
  • B. Lu et al.

    Regulation of HMGB1 release by inflammasomes

    Protein Cell

    (2013)
  • H. Wang et al.

    HMG-1 as a late mediator of endotoxin lethality in mice

    Science

    (1999)
  • S. Qin et al.

    Role of HMGB1 in apoptosis-mediated sepsis lethality

    J. Exp. Med.

    (2006)
  • A. Rouhiainen et al.

    Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation

    Thromb. Haemost.

    (2000)
  • S. Vogel et al.

    Platelet-derived HMGB1 is a critical mediator of thrombosis

    J. Clin. Invest.

    (2015)
  • P. Scaffidi et al.

    Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

    Nature

    (2002)
  • E. Venereau et al.

    Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release

    J. Exp. Med.

    (2012)
  • S. Nystrom et al.

    TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis

    EMBO J.

    (2013)
  • Y. Sha et al.

    HMGB1 develops enhanced proinflammatory activity by binding to cytokines

    J. Immunol.

    (2008)
  • V. Urbonaviciute et al.

    Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE

    J. Exp. Med.

    (2008)
  • Cited by (222)

    View all citing articles on Scopus
    View full text